精品一久久_日韩成人激情_av2016天堂网_国产成年片_日日影视_精品国产观看

更新于 5月27日

Senior Scientist, Large Molecular BA (MJ015963)

1.6-1.8萬·14薪
  • 上海浦東新區
  • 經驗不限
  • 碩士
  • 全職
  • 招1人

職位描述

生物藥
General Description: The DMPK Department of BeiGene is seeking an experienced individual contributor of the large molecule Bioanalytical scientist at its newly established Shanghai Research Center. The successful candidate must have in depth knowledge of quantitative measurement or qualitative understanding of large molecules using ELISA or LC-MS/MS, deliver high quality and timely scientific support to the study. Responsibilities:
  • Responsible for pharmacokinetic and bio-sample analysis for mabs, BsAbs, ADCs and fusion proteins, during drug research and development;
  • Proficient in the use and maintenance of microplate reader, MSD and LC-MS/MS;
  • Responsible for the establishment of bioanalytical methods and bioanalysis in various biological matrix;
  • Responsible for data processing, analysis and report writing;
  • be still in hands-on experimental operation
Requirements:
  • Master degree in Biochemistry/Biology/Cell Biology/Pharmacokinetics or a related scientific field;
  • Experience in the development of biologics such as monoclonal antibodies, ADC or bispecific Ab.
百濟神州全球勝任力 當我們通過以下十二項全球勝任力,展現出 "患者為先"、"無界協作"、"銳意創新 "和 "追求卓越 "的價值觀時,我們就能幫助全世界更多患者獲得更多負擔得起的藥品。 ●團隊協作 ●提供并征求坦誠及可行的反饋 ●自我認知 ●兼容并蓄 ●積極主動 ●開拓精神 ●持續學習 ●擁抱變化 ●結果導向 ●分析性思維/數據分析 ●卓越財務 ●清晰溝通 BeiGene Global Competencies When we exhibit our values of Patients First, Collaborative Spirit, Bold Ingenuity and Driving Excellence, through our twelve global competencies below, we help get more affordable medicines to more patients around the world. ●Fosters Teamwork ●Provides and Solicits Honest and Actionable Feedback ●Self-Awareness ●Acts Inclusively ●Demonstrates Initiative ●Entrepreneurial Mindset ●Continuous Learning ●Embraces Change ●Results-Oriented ●Analytical Thinking/Data Analysis ●Financial Excellence ●Communicates with Clarity 求職者隱私申明: 百濟神州致力于尊重和保護您的個人信息權利,并承諾依據合法、正當、必要和誠信的原則處理您的個人信息(包括個人敏感信息 )。 由于百濟神州在全球范圍內開展業務,我們可能需要基于人力資源管理等合理業務目的而將您的個人信息發送和/或存儲在位于您所在國家以外其他國家(例如:美國)的服務器和數據庫中,詳情參見百濟神州《求職者隱私政策》(百濟神州官網 - 隱私政策 - 求職者隱私政策)。 如您主動向我們提供您的簡歷信息或其他個人信息,則視為您已經充分理解并確認接受百濟神州《求職者隱私政策》內容。如您對此有任何疑問的,請勿提交簡歷信息或其他個人信息。 BeiGene is committed to respect and protect your personal information rights, and will process your personal information, including your sensitive personal information, based on the principles of legality, legitimacy, necessity, and integrity. Due to the reasonable business need for human resource management as a result of BeiGene’s global operation, your personal information may be transferred and/ or stored in a server/database located in a third country (e.g., the United States) other than your own country. For further details, please refer to BeiGene Job Applicant Privacy Policy (BeiGene official website - Privacy Policy - Job Applicant Privacy Policy). If you voluntarily provide your resume or other personal information to us, it is deemed as you have thoroughly acknowledged and accepted BeiGene Job Applicant Privacy Policy. If you have any concern, please DO NOT submit your resume or any other personal information.

工作地點

浦東新區百濟神州(上海)醫藥研發有限公司

職位發布者

張婧媛/百濟神州研發招聘recruiter

剛剛活躍
立即溝通
公司Logo百濟神州北京
About BeiGene BeiGene is a publically traded(BGNE, NASDAQ), globally focused biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer. Our cancer biology platform addresses the importance of tumor-immune system interactions and the value of primary tumor biopsies in developing new cancer models. We have a global team of over 200 individuals, including over 150 scientists and clinicians, and a world-renowned scientific advisory board, with deep scientific talent, extensive pharmaceutical experience, and a commitment to improving the lives of cancer patients around the world. Our clinical pipeline is comprised of novel oral small molecules and monoclonal antibodies(mAb) for cancer, including an anti-PD-1 monoclonal antibody, a best-in-class BTK inhibitor, a RAF dimer inhibitor, a best-in-class PARP inhibitor, and a variety of combination clinical studies. In addition, our robust preclinical programs are expected to generate more small molecule and mAb drugs for clinical development in coming years. For more information, please visit our website at www.beigene.com.
公司主頁
主站蜘蛛池模板: 亚洲欧洲美洲精品一区二区三区 | 久久亚洲综合色 | 两个人高清在线观看www | 亚洲伊人色欲综合网 | 日产乱码一二三区别免费麻豆 | 亚洲国产一区av | 亚洲成人福利在线观看 | 天堂一区二区三区 | 久久99婷婷国产精品免费 | 亚洲AV无码午夜国产精品色软件 | 国产香蕉精品视频老妇 | 84pao国产成人高清在线 | 黄网站网址大全免费的 | 久久久999 | 亚洲天堂成人av | 137大胆人体在线观看 | 国产高清美女一级a毛片久久w | 粉嫩蜜臀av国产精品网站 | 日本地区不卡一区二区三区搜索 | 日日久视频 | 第一福利在线 | 7777精品伊久久久大香线蕉 | 精品精品视频 | 女性裸体无遮挡无遮掩视频蜜芽 | 日韩欧美视频免费在线观看 | 福利姬国产在线观看免费 | 二区久久| 4438╳全国最大色倩网址 | 久久亚洲av无码精品色午夜麻 | 国产呦精品一区二区三区网站 | 520av视频| 内射老阿姨1区2区3区4区 | 国产成人92精品午夜福利 | 久久久久久综合岛国免费观看 | 国产好吊视频在线观看 | 国产女做a爱免费视频 | 日本50岁丰满熟妇xxxx | 国产精品第一区第27页 | 女性女同性aⅴ免费观女性恋 | 丰满的人妻HD高清日本 | 久久久久人妻精品一区蜜桃 |